Clinical Edge Journal Scan

ADHD Behavioral Patterns Linked to Prurigo Nodularis Development in Children With Atopic Dermatitis


 

Key clinical point: Specific behavioral patterns of attention-deficit/hyperactivity disorder, such as impulsivity and hyperactivity, were associated with the development of prurigo nodularis (PN) in children with atopic dermatitis (AD), regardless of AD severity.

Major finding: Among children with AD, the impulsivity/hyperactivity score was significantly higher in those with vs without PN (5.5 ± 4.2 vs 2.9 ± 2.9; P = .038); no significant differences were observed in Eczema Area Severity Index scores, itch numeric rating scale scores, or other AD outcomes in children with vs without PN ( P > .05).

Study details: This cross-sectional study included 39 children with AD who did (n = 21) or did not (n = 18) have PN.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Kim Y, Lee J, Shin K, et al. Association between prurigo nodularis and behavioural patterns of attention-deficit/hyperactivity disorder in children with atopic dermatitis: A cross-sectional study. J Eur Acad Dermatol Venereol. 2024(Mar 27). doi: 10.1111/jdv.19967 Source

Recommended Reading

How Does Moderate to Severe Eczema Affect Growth in Children?
MDedge Dermatology
Atopic Dermatitis in Early Life Tied to Subsequent Risk for Inflammatory Bowel Disease
MDedge Dermatology
Tralokinumab Normalizes Expression of Inflammatory Biomarkers in Atopic Dermatitis
MDedge Dermatology
No Improvement in Atopic Dermatitis Severity Upon Vitamin D Supplementation
MDedge Dermatology
Passive Smoking May Increase the Risk for Atopic Dermatitis in Offspring
MDedge Dermatology
Atopic Dermatitis Increases the Risk for Lymphoma
MDedge Dermatology
Real-World Study Confirms Efficacy of Baricitinib in Atopic Dermatitis
MDedge Dermatology
Filaggrin Loss-of-Function Variants Associated With Atopic Dermatitis Outcomes
MDedge Dermatology
Dupilumab Treatment for Atopic Dermatitis Increases Risk for Cutaneous T-Cell Lymphoma
MDedge Dermatology
Upadacitinib Improved Patient-Reported Outcomes in Atopic Dermatitis
MDedge Dermatology